Immunovant (IMVT) Held by Superinvestors
IMMUNOVANT INC (IMVT) is currently held by 2 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $31.61M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Renaissance Technologies LLC is currently the largest disclosed institutional shareholder of IMVT tracked by InsiderSet, reporting ownership valued at approximately $28.00M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $20.63M, representing an estimated loss of -26.34% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed IMVT value among the investors covered in this analysis. Major shareholders include Renaissance Technologies LLC, Greenlight Capital, and several other long-term asset managers with concentrated positions in IMMUNOVANT INC (IMVT).
This page ranks the largest institutional IMVT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Jim Simons | 0.04% | 726,800 | $28,003,604 | $20,626,584 | -$7,377,020 | -26.34% |
| Greenlight Capital | David Einhorn | 0.09% | 93,520 | $3,603,325 | $2,654,098 | -$949,227 | -26.34% |
Frequently asked questions about IMVT
Who are the largest superinvestors holding IMVT?
The largest superinvestors holding IMVT in the latest SEC Form 13F filings include Renaissance Technologies LLC and Greenlight Capital. InsiderSet ranks these superinvestors by their latest reported IMVT position.
What does the IMVT superinvestors page include?
This page tracks IMVT positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. IMMUNOVANT INC (IMVT) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold IMVT?
InsiderSet currently tracks 2 superinvestors reporting IMVT holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own IMVT.
How much IMVT stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $31.61M in IMVT holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were IMVT superinvestor holdings last updated?
The latest IMVT superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor IMVT holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its IMVT position after the reporting date.
Are superinvestors buying or selling IMVT?
Buying and selling can be analyzed by comparing IMVT positions across consecutive 13F reporting periods. InsiderSet's IMVT Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View IMVT ownership changes.
How have superinvestor IMVT holdings changed over time?
InsiderSet tracks IMVT holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.